Effects of Pioglitazone [Actos] on the Regulation of Insulin Secretion in Patients With Type 2 Diabetes.

Next Previous
Trial Profile

Effects of Pioglitazone [Actos] on the Regulation of Insulin Secretion in Patients With Type 2 Diabetes.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Feb 2016

At a glance

  • Drugs Pioglitazone (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics

    • Most Recent Events

    • 17 Feb 2016 Results of this and other trial published in the Obesity (Silver Spring, Md.)
    • 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
    • 05 Oct 2011 Results presented at the 2011 Annual Meeting of the North American Association for the Study of Obesity.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top